| Needs
Assessment
Through needs assessment surveys, literature searches, advisory
board suggestions, and recent specialty publications, ImproMED
has identified that a need exists to educate ophthalmologists
on glaucoma detection, prevention, diagnosis, and treatment.
With more than 7 million visits to physicians in the United
States alone each year due to glaucoma, there is a significant
need to provide comprehensive education to physicians who
detect, diagnose, and treat this disease.
Target
Audience
General ophthalmologists. Secondary audience: ophthalmic
residents and primary care physicians who refer patients
with symptoms of glaucoma to ophthalmologists.
Overall
Purpose
The purpose of this activity is to provide ophthalmologists
an understanding of a range of general glaucoma subjects,
with a focus on recent advances in the field.
Educational Objectives
Upon completion of this CME activity, participants should
have increased overall skills, knowledge, attitudes, and
performance, with a specific ability to:
Skill(s)
Differentiate between the various types of glaucoma
Knowledge
Identify anatomical parts of the eye affected by glaucoma
and its treatment
Describe baseline demographic and clinical factors that
help predict which patients are likely to develop glaucoma
Attitude(s)
Recognize the clinical implications from recent developments
in glaucoma
Performance
Assess the pharmacological and surgical treatment options
commonly used in patients with glaucoma.
Designation of Credit Statement
ImproMED designates this educational activity for a maximum
of 1.0 category 1 credit toward the AMA Physician’s
Recognition Award. Each physician should claim only those
credits that he/she actually spent in the activity.
Disclosure Policy
It is the policy of ImproMED to ensure balance, independence,
objectivity, and scientific rigor in all its sponsored educational
activities. All faculty are expected to disclose to program
audiences any significant relationships related to the content
of their presentations.
Unapproved
uses of drug regimens may be discussed.
 Activity
Review Committee
This activity was reviewed by Richard
K. Parrish II, MD, Activity Chair,
James Spindler,
MD, and Suzanne
Eggers.
Term of Approval: December 2003 through December 2004.
The certification periods for the following activities have expired, but the programs remain available for viewing. Please note that your participation in these activities is not eligible for AMA PRA category 1 credit, but may be eligible for AMA PRA category 2 credit. Please contact ImproMED with questions (seggers@impromed.org or 269.329.0651 x31) or view the AMA guidelines for PRA credit at http://www.ama-assn.org/ama/pub/category/2938.html.
|
